Bambuterol

Drug Profile

Bambuterol

Alternative Names: Bambec; KWD 2183

Latest Information Update: 09 May 2007

Price : $50

At a glance

  • Originator Draco Lakemedel
  • Class Antiasthmatics; Bronchodilators; Ethanolamines; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Marketed Asthma; Bronchitis; Emphysema; Respiratory tract disorders

Most Recent Events

  • 22 Aug 2000 Astra Draco is now called Draco Läkemedel
  • 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed
  • 16 Sep 1997 Launched for Respiratory tract disorders in Thailand (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top